脑出血（英文）2024，Vol.5Issue(2)：39-45,7.DOI:10.1016/j.hest.2023.10.005
Could clazosentan,first approved in Japan,improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management
Could clazosentan,first approved in Japan,improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management
Eiji Shikata 1Yasuhisa Kanematsu 2Yasushi Takagi 2Izumi Yamaguchi 2Masaaki Korai 2Takeshi Miyamoto 2Tadashi Yamaguchi 2Hiroshi Kagusa 2Kenji Shimada 2Yoshiteru Tada 2Keiko T.Kitazato2
作者信息
- 1. Department of Neurosurgery,Graduate School of Biomedical Sciences,Tokushima University,Kuramoto-cho,Tokushima,Japan||Department of Neurosurgery,Takamatsu Municipal Hospital,Busshozan-cho,Kagawa,Japan
- 2. Department of Neurosurgery,Graduate School of Biomedical Sciences,Tokushima University,Kuramoto-cho,Tokushima,Japan
- 折叠
摘要
关键词
Aneurysmal subarachnoid hemorrhage/Cerebral vasospasm/Endothelin/Blood-brain barrier disruption/Clazosentan/Water-electrolyte managementKey words
Aneurysmal subarachnoid hemorrhage/Cerebral vasospasm/Endothelin/Blood-brain barrier disruption/Clazosentan/Water-electrolyte management引用本文复制引用
Eiji Shikata,Yasuhisa Kanematsu,Yasushi Takagi,Izumi Yamaguchi,Masaaki Korai,Takeshi Miyamoto,Tadashi Yamaguchi,Hiroshi Kagusa,Kenji Shimada,Yoshiteru Tada,Keiko T.Kitazato..Could clazosentan,first approved in Japan,improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management[J].脑出血（英文）,2024,5(2):39-45,7.
